FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE

Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: O. D. Ostroumova, I. I. Kopchenov
Format: Artigo
Idioma:Inglês
Publicat: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Col·lecció:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Matèries:
arterial hypertension
combined therapy
fixed combinations of antihypertensive drugs
ace inhibitors
calcium antagonists
enalapril, lercanidipine
Accés en línia:https://www.rpcardio.com/jour/article/view/284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars